07.09.26 -- Reducing Release Timelines

While visible particles often draw immediate attention, visual inspection alone is insufficient, as subvisible particulate matter can pose equally significant risks to patient safety.

Accelerate GLP-1 and peptide therapy development with integrated drug containment, delivery, machinery, and analytics for reliable combination product performance.

In this segment from the Pharmaceutical Online Live event, our panelists talk about reducing release timelines with NIR spectrophotometry, the biggest bottlenecks to release testing, AI assisting in release testing, and how companies are approaching real time release testing.

Rising molecular complexity and tighter timelines push manufacturing beyond batch processes. Continuous, automated flow enables faster scale-up, safer handling, and efficiency without sacrificing quality.

A fireside chat explores spray drying basics, oral biologic dosage forms, formulation hurdles, and testing strategies to ensure drug product quality, safety, and performance.

Optimize drug delivery by leveraging advanced nanoparticle engineering to dramatically increase small-molecule oral drug loading and enable ultra-high-concentration subcutaneous formulations.